FDA Recalls Sexual Enhancement Supplement for Undeclared Prescription Drugs

On May 11, 2026, Best Supplements Best Prices issued a voluntary nationwide recall of WAP Sensual Enhancement capsules after FDA laboratory analysis revealed the product contains three undeclared prescription-grade active ingredients: sildenafil, tadalafil, and flibanserin. The capsules, marketed as a dietary supplement for sexual enhancement and sold online via eBay, pose significant health risks—particularly for consumers taking nitrate medications or those with cardiovascular conditions, diabetes, or high blood pressure. The undeclared ingredients can trigger dangerous blood pressure drops, fainting, and harmful drug interactions that may prove life-threatening in susceptible populations.

What Happened

Best Supplements Best Prices, a Los Angeles–based supplement distributor, discovered through FDA laboratory testing that its WAP Sensual Enhancement product (UPC 80174 00462) contained three prescription drugs sold under brand names Viagra, Cialis, and Addyi without any label disclosure. The company initiated a voluntary recall at the consumer level in May 2026, notifying customers via email and offering full refunds. The product had been sold nationwide through internet retailers, particularly eBay, and was marketed without any pharmaceutical ingredient disclosure on the label or in marketing materials.

Best Supplements Best Prices established a hotline (818-856-2141, Monday–Saturday, 9am–5pm PT) and email address (eroticenhancers@gmail.com) for consumers seeking refunds or product information. The company instructed all consumers to stop using the product immediately and dispose of remaining capsules, and stated it is working cooperatively with the FDA.

What the Source Says

According to the FDA's official recall announcement, sildenafil and tadalafil are FDA-approved prescription medications for erectile dysfunction that work by dilating blood vessels and reducing vascular resistance. Both agents lower blood pressure as a secondary effect. When combined with nitrates—common medications for angina and heart disease such as nitroglycerin and isosorbide dinitrate—these drugs can trigger a potentially life-threatening drop in blood pressure, particularly in patients with existing cardiovascular disease, diabetes, high cholesterol, or hypertension.

Flibanserin, marketed as Addyi, is an FDA-approved prescription medication for low sexual desire in women and operates through a different mechanism, targeting serotonin and dopamine receptors in the brain. The FDA warns that flibanserin causes drowsiness, sedation, and dangerously low blood pressure and fainting, especially when combined with alcohol. Because alcohol frequently accompanies sexual activity, the presence of undeclared flibanserin in a supplement creates acute risk of syncope (fainting) and related injuries.

The FDA's analysis did not disclose exact concentrations of each drug in the capsules, but the presence of all three prescription-grade active ingredients in a single unmarked product—without dosage information, contraindication warnings, or medical supervision—represents a severe violation of both FDA dietary supplement labeling requirements and standard pharmaceutical safety practices.

Beyond the Headline

This recall reflects a persistent pattern of adulterated sexual-enhancement and weight-loss supplements reaching U.S. consumers. The FDA and the dietary supplement industry have engaged in enforcement battles over undeclared pharmaceutical ingredients in these product categories for over a decade. These products exploit weak supplement labeling enforcement and consumer desires for quick results, often targeting individuals who may avoid prescription routes due to cost, embarrassment, or lack of medical access.

Unlike prescription drugs, dietary supplements do not require pre-market FDA approval under current law; manufacturers bear the responsibility for safety and labeling accuracy, but FDA enforcement remains reactive—triggered primarily by consumer complaints, adverse events reports, or agency laboratory testing. The WAP Sensual Enhancement recall underscores the challenge of online marketplaces enabling the sale of adulterated supplements. E-commerce platforms such as eBay process thousands of supplement transactions daily; detecting and removing products containing undeclared drugs requires either consumer complaint escalation or proactive FDA sampling and testing efforts.

This case also highlights the vulnerability of consumers purchasing sexual-health products online without medical consultation, making them less aware of potential dangerous drug interactions with existing medications or medical conditions.

What This Means for Consumers

Immediate action: Consumers who purchased WAP Sensual Enhancement capsules should stop using the product immediately. Contact Best Supplements Best Prices at 818-856-2141 (Monday–Saturday, 9am–5pm PT) or eroticenhancers@gmail.com to request a refund. Dispose of remaining capsules safely in household trash (do not flush unless instructed on the bottle label).

If you have heart disease, take nitrates, or use blood-pressure medication: Sildenafil and tadalafil are contraindicated—meaning they should never be taken together—with nitrate drugs. If you consumed WAP Sensual Enhancement while taking nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, or other nitrate medications, contact your physician immediately or call Poison Control at 1-800-222-1222 in the U.S. Seek emergency care if you experience chest pain, shortness of breath, severe dizziness, fainting, vision changes, or sudden hearing loss.

If you consumed the product with alcohol: The undeclared flibanserin component significantly increases risk of severe hypotension and fainting when combined with alcohol. If you experienced dizziness, loss of consciousness, unexplained falls, or other adverse symptoms after using this product with alcohol, seek medical attention immediately. Report the incident to the FDA via MedWatch (www.fda.gov/medwatch/report.htm) or call 1-800-332-1088. Detailed adverse event reporting helps the FDA identify patterns and protect other consumers.

Safer alternatives: If you seek pharmaceutical treatment for erectile dysfunction or low sexual desire, consult a licensed healthcare provider who can assess your medical history, current medications, and contraindications before prescribing. Prescription options are safer precisely because they include accurate dosing, personalized contraindication screening, and ongoing medical supervision. If cost is a barrier, ask your physician about generic sildenafil or tadalafil—both are now affordable and widely available with a valid prescription. For supplements marketed for sexual wellness, select products with transparent ingredient lists, third-party testing seals (NSF Certified for Sport, USP Verified, or ConsumerLab), and no claims of pharmaceutical efficacy or disease treatment.

What to Watch Next

The FDA will likely continue monitoring for additional undeclared-drug supplements in the sexual-enhancement category. Consumers should monitor FDA MedWatch alerts on the agency's website for adverse events reported from WAP Sensual Enhancement or similar recalled products. Best Supplements Best Prices' full refund program should be completed within 30–60 days; consumers who do not receive refunds should escalate complaints to the FDA's consumer complaint portal.

On a regulatory level, watch for renewed FDA enforcement actions or warning letters to other supplement companies selling similar adulterated products. The agency has occasionally proposed stricter pre-market notification requirements for supplement manufacturers, though legislative change remains slow. Consumer advocacy groups have called for mandatory third-party testing and stricter marketplace oversight of supplement sellers on platforms like Amazon and eBay—steps that could reduce future recalls but have not yet been implemented at industry scale.